{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:11:56Z","timestamp":1793218316626,"version":"4.5.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007293","name":"Obesity Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018488","name":"UF CTSI","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100018488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study compared in vivo changes in hepatic phosphate metabolites using phosphorus magnetic resonance spectroscopy (31P-MRS) in patients with vs without metabolic dysfunction-associated steatotic liver disease (MASLD) after oral fructose consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-seven overweight or obese patients without diabetes underwent a 2-hour oral glucose tolerance test, a fasting liver proton magnetic resonance spectroscopy, and a 31P-MRS before and during 60 minutes after an oral 75-gram fructose challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Before fructose consumption, there were no differences in ATP, phosphomonoesters (PME), or phosphodiesters between groups. After fructose, patients without MASLD had a rapid increase in PME (from 15.5 \u00b1 4.8 to 19.3 \u00b1 5.1 within 15 minutes, P = .033). In these patients, inorganic phosphate (Pi) decreased during the first 30 minutes but then increased, leading to higher than baseline levels (from 10.2 \u00b1 1.9 to 11.8 \u00b1 2.8, P = .037). ATP significantly dropped in patients without MASLD within 15 minutes (from 21.8 \u00b1 3.4 to 19.9 \u00b1 4.0, P = .018), with persistently lower levels after 60 minutes (19.1 \u00b1 4.1, P = .006 vs baseline). However, all these responses to oral fructose appeared blunted in patients with MASLD, with unchanged PME levels and only showing an Pi increase 45 minutes after fructose consumption. ATP levels showed a nonsignificant drop in the first 15 minutes with recovery of baseline levels at minute 30.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Following fructose consumption, patients with MASLD exhibited distinct patterns of change in phosphate metabolites, reflecting differences in hepatic metabolic responses. These findings suggest altered hepatic metabolic handling of fructose in MASLD, which may have implications for disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag125","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:40:50Z","timestamp":1773924050000},"page":"2620-2629","source":"Crossref","is-referenced-by-count":1,"title":["Patients with MASLD exhibit in vivo changes in hepatic response to oral fructose consumption"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-4396","authenticated-orcid":false,"given":"Fernando","family":"Bril","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham , Birmingham, AL 35233 ,","place":["USA"]},{"name":"Division of Endocrinology, Diabetes and Metabolism, Birmingham VA Medical Center , Birmingham, AL 35233 ,","place":["USA"]},{"name":"UAB Comprehensive Diabetes Center , Birmingham, AL 35233 ,","place":["USA"]},{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Florida , Gainesville, FL 32608 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C","family":"Forbes","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, University of Florida , Gainesville, FL 32610 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7009-264X","authenticated-orcid":false,"given":"Srilaxmi","family":"Kalavalapalli","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Florida , Gainesville, FL 32608 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-418X","authenticated-orcid":false,"given":"Kenneth","family":"Cusi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Florida , Gainesville, FL 32608 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"4","key":"2026081219570062200_dgag125-B1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.28985","article-title":"Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"2026081219570062200_dgag125-B2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"2026081219570062200_dgag125-B3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"issue":"4","key":"2026081219570062200_dgag125-B4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2337\/dc21-1758","article-title":"Impaired hepatic mitochondrial capacity in nonalcoholic steatohepatitis associated with type 2 diabetes","volume":"45","author":"Gancheva","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"2026081219570062200_dgag125-B5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"issue":"4","key":"2026081219570062200_dgag125-B6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2026081219570062200_dgag125-B7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"issue":"1","key":"2026081219570062200_dgag125-B8","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","article-title":"Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration","volume":"13","author":"Pedersen","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"2026081219570062200_dgag125-B9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"issue":"8","key":"2026081219570062200_dgag125-B10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.metabol.2010.12.001","article-title":"Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo","volume":"60","author":"Wang","year":"2011","journal-title":"Metabolism"},{"issue":"4","key":"2026081219570062200_dgag125-B11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI86695","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"126","author":"Satapati","year":"2016","journal-title":"J Clin Invest"},{"issue":"4","key":"2026081219570062200_dgag125-B12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2013.11.020","article-title":"Liver adapts mitochondrial function to insulin resistant and diabetic states in mice","volume":"60","author":"Franko","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"2026081219570062200_dgag125-B13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J Hepatol"},{"issue":"2-3","key":"2026081219570062200_dgag125-B14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02668096","article-title":"Java-based graphical user interface for the MRUI quantitation package","volume":"12","author":"Naressi","year":"2001","journal-title":"MAGMA"},{"issue":"3","key":"2026081219570062200_dgag125-B15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.clnu.2015.04.001","article-title":"Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: a (31)P MRS study","volume":"35","author":"Bawden","year":"2016","journal-title":"Clin Nutr"},{"issue":"1","key":"2026081219570062200_dgag125-B16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"2026081219570062200_dgag125-B17","unstructured":"Bril F . Online Supplemental Content. 2026, Zenodo. 10.5281\/zenodo.18763649. Accessed February 24, 2026"},{"issue":"17","key":"2026081219570062200_dgag125-B18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"2026081219570062200_dgag125-B19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiol.10091351","article-title":"Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling","volume":"256","author":"Sevastianova","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"2026081219570062200_dgag125-B20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejrad.2007.06.004","article-title":"Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy","volume":"66","author":"Noren","year":"2008","journal-title":"Eur J Radiol"},{"issue":"1","key":"2026081219570062200_dgag125-B21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2008.06.016","article-title":"Investigation of hepatic gluconeogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo ((31)P) phosphorus magnetic resonance spectroscopy","volume":"203","author":"Sharma","year":"2009","journal-title":"Atherosclerosis"},{"key":"2026081219570062200_dgag125-B22","first-page":"417","article-title":"Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances","volume":"21","author":"Menon","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"2026081219570062200_dgag125-B23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gut.39.1.141","article-title":"Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models","volume":"39","author":"Jalan","year":"1996","journal-title":"Gut"},{"issue":"2","key":"2026081219570062200_dgag125-B24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1148\/radiology.171.2.2704824","article-title":"Effect of intravenous fructose on the P-31 MR spectrum of the liver: dose response in healthy volunteers","volume":"171","author":"Terrier","year":"1989","journal-title":"Radiology"},{"issue":"9","key":"2026081219570062200_dgag125-B25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0730-725X(97)00163-X","article-title":"Effect of ethanol and fructose on liver metabolism: a dynamic 31Phosphorus magnetic resonance spectroscopy study in normal volunteers","volume":"15","author":"Boesch","year":"1997","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"2026081219570062200_dgag125-B26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jmri.1880010615","article-title":"Serial P-31 MR spectroscopy after fructose infusion in patients with chronic hepatitis","volume":"1","author":"Sakuma","year":"1991","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2026081219570062200_dgag125-B27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hep.1840150515","article-title":"Alterations in hepatic fructose metabolism in cirrhotic patients demonstrated by dynamic 31phosphorus spectroscopy","volume":"15","author":"Dufour","year":"1992","journal-title":"Hepatology"},{"issue":"6","key":"2026081219570062200_dgag125-B28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"issue":"11","key":"2026081219570062200_dgag125-B29","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"J Clin Invest"},{"issue":"7","key":"2026081219570062200_dgag125-B30","doi-asserted-by":"crossref","first-page":"115962","DOI":"10.1016\/j.celrep.2025.115962","article-title":"ANGPTL3 orchestrates hepatic fructose sensing and metabolism","volume":"44","author":"Zhao","year":"2025","journal-title":"Cell Rep"},{"issue":"2","key":"2026081219570062200_dgag125-B31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/joim.13729","article-title":"Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis","volume":"295","author":"De Vito","year":"2024","journal-title":"J Intern Med"},{"issue":"3","key":"2026081219570062200_dgag125-B32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/oby.23653","article-title":"Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum","volume":"31","author":"Fiorentino","year":"2023","journal-title":"Obesity"},{"issue":"3","key":"2026081219570062200_dgag125-B33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ijpo.238","article-title":"Oral fructose absorption in obese children with non-alcoholic fatty liver disease","volume":"10","author":"Sullivan","year":"2015","journal-title":"Pediatr Obes"},{"issue":"1","key":"2026081219570062200_dgag125-B34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00019.2009","article-title":"Metabolic effects of fructose and the worldwide increase in obesity","volume":"90","author":"Tappy","year":"2010","journal-title":"Physiol Rev"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag125\/67473099\/dgag125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/2620\/67473099\/dgag125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/2620\/67473099\/dgag125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:57:15Z","timestamp":1786579035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/9\/2620\/8537218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag125","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,3,20]]}}}